RG6156 / Roche  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RG6156 / Roche
NCT05187624: A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma

Active, not recruiting
1
200
Europe, Canada, US, RoW
RO7428731
Hoffmann-La Roche
Glioblastoma
12/25
12/25

Download Options